
Julian Panés
Jefe de la UnidadPublicaciones destacadas
-
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease
Autores: Ordás I, Rimola J, Alfaro I, Rodríguez S, Castro-Poceiro J, Ramírez-Morros A, Gallego M, Giner À, Barastegui R, Fernández-Clotet A, Masamunt M, Ricart E, Panés J .Referencia: Gastroenterology 2019. -
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Autores: Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators.Referencia: Gastroenterology 2018. -
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Autores: Dotti I., Mora-Buch R., Ferrer-Picón E., Planell N., Jung P., Masamunt M., Leal R., De Carpi J., Llach J., Ordás I., Batlle E., Panés J., Salas A..Referencia: Gut 2017. -
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Autores: Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E .Referencia: Gut 2017. -
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Autores: Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine; Schreiber, Stefan; Danese, Silvio; Feagan, Brian G.; Reinisch, Walter; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian;OCTAVE Induction 1 OCTAVE Inductio.Referencia: New England Journal Of Medicine 2017. -
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
Autores: Jauregui-Amezaga A, Rovira M, Marín P, Salas A, Pinó-Donnay S, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Mensa J, Rimola J, Rodríguez S, Masamunt MC, Comas D, Ruíz I, Ramírez-Morros A, Gallego M, Ordás I, Panés J, Ricart E .Referencia: Gut 2016. -
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile
Autores: Calderon-Gomez, Elisabeth; Bassolas-Molina, Helena; Mora-Buch, Rut; Dotti, Isabella; Planell, Nuria; Esteller, Miriam; Gallego, Marta; Marti, Merce; Garcia-Martin, Carme; Martinez-Torro, Carlos; Ordas, Ingrid; Singh, Sharat; Panes, Julian; Benitez-Ribas, Daniel; Salas, Azucena;.Referencia: Gastroenterology 2016. -
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial
Autores: Panes J; Garcia-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S.Referencia: Lancet 2016. -
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
Autores: Rimola, J; Rodriguez, S; Garcia-Bosch, O; Ordas, I; Ayala, E; Aceituno, M; Pellise, M; Ayuso, C; Ricart, E; Donoso, L; Panes, J.Referencia: Gut 2009.
Proyectos destacados
-
Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)
Investigador/a principal: Maria Azucena Salas Martinez, Julian Panes DiazFinanciador: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)Código: RTI2018-096946-B-I00Duración: 01/01/2019 - 31/12/2021 -
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease
Investigador/a principal: Elena RicartFinanciador: Instituto de Salud Carlos III (Programa financiador competitivo)Código: PI17/00513Duración: 01/01/2018 - 31/12/2020 -
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues
Investigador/a principal: Maria Azucena Salas MartinezFinanciador: The Leona M and Harry B Helmsley Charitable TrustCódigo: HemsleyDuración: 02/01/2014 - 31/12/2017 -
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3
Investigador/a principal: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes DiazCódigo: NEW DEAL H2020Duración: 01/01/2017 - 31/12/2020 -
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)
Investigador/a principal: Julian Panes DiazCódigo: SAF 2012-33560Duración: 02/01/2013 - 31/12/2015